← Leaderboards
Michele Cresap
Pelagos Pharmaceuticals, Inc.
$540,432
Attributed
$540,432
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $449.5K · FY2022–23$500K$375K$250K$125K$0
'22
'23
Funding mix
By agency
NIH$540,432 · 1
By mechanism
R41$540,432 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposImpaired CognitionAgonistDoctor Of PhilosophyGlial ActivationIl18 GeneChronicAwardCostDisease ProgressionFailureAging PopulationAnimal ModelHigh Throughput ScreeningClinical TrialsAffectBrainCapitalEffective TherapyCause Of DeathCytokineDementiaAmericanInflammasome